Gonadorelin

Gonadorelin is synthetic gonadotropin-releasing hormone, or GnRH, which physiologically links the hypothalamus to pituitary release of luteinizing hormone and follicle-stimulating hormone. Its evidence base is older and highly context-dependent. In humans, native GnRH has been used diagnostically to assess pituitary gonadotropin reserve and therapeutically in carefully timed pulsatile regimens for selected hypothalamic reproductive disorders. Pulsatile administration matters because continuous stimulation can produce different endocrine effects than physiologic pulses. Current U.S. DailyMed gonadorelin entries located during research are primarily veterinary products, so this page should avoid implying a currently marketed human U.S. indication unless a specific approved human label is supplied.

HPG-Axis Physiology

GnRH regulates the hypothalamic-pituitary-gonadal axis by stimulating pituitary LH and FSH release ^[1].

Diagnostic and Specialist Context

Native GnRH/gonadorelin has historical diagnostic use for evaluating pituitary gonadotropin reserve and pulsatile GnRH has been studied in hypothalamic amenorrhea ^[2][3].

Evidence Boundary

Evidence does not support broad claims for bodybuilding, testosterone enhancement, or nonmedical endocrine optimization.

Label and Indication Caution

Current U.S. DailyMed gonadorelin labels located during research are veterinary, so do not imply an active U.S. human prescription indication from those records ^[4].

Endocrine Monitoring Required

Human gonadorelin use requires endocrine diagnosis, route-specific dosing, and monitoring. Continuous versus pulsatile exposure can have different physiologic effects ^[1][2].